Latest filing published 24 Feb 2026 for Dr. Lal Path Labs Ltd., €14k. Read the official filing
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Dr. Lal PathLabs Employees Welfare Trust in Dr. Lal Path Labs Ltd., where the filings describe the role as chief executive. In total, 159 filings cover trades dated from 7 May 2021 to 24 February 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 24 February 2026 came the latest disclosure, a share grant for €14k in Dr. Lal Path Labs Ltd. The median gap between a trade and its publication by SEBI (PIT + SAST) is 1 day. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 159 declarations